Correlation Between Virax Biolabs and Pmv Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Virax Biolabs and Pmv Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Virax Biolabs and Pmv Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Virax Biolabs Group and Pmv Pharmaceuticals, you can compare the effects of market volatilities on Virax Biolabs and Pmv Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Virax Biolabs with a short position of Pmv Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Virax Biolabs and Pmv Pharmaceuticals.
Diversification Opportunities for Virax Biolabs and Pmv Pharmaceuticals
-0.11 | Correlation Coefficient |
Good diversification
The 3 months correlation between Virax and Pmv is -0.11. Overlapping area represents the amount of risk that can be diversified away by holding Virax Biolabs Group and Pmv Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pmv Pharmaceuticals and Virax Biolabs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Virax Biolabs Group are associated (or correlated) with Pmv Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pmv Pharmaceuticals has no effect on the direction of Virax Biolabs i.e., Virax Biolabs and Pmv Pharmaceuticals go up and down completely randomly.
Pair Corralation between Virax Biolabs and Pmv Pharmaceuticals
Given the investment horizon of 90 days Virax Biolabs Group is expected to under-perform the Pmv Pharmaceuticals. In addition to that, Virax Biolabs is 3.58 times more volatile than Pmv Pharmaceuticals. It trades about -0.1 of its total potential returns per unit of risk. Pmv Pharmaceuticals is currently generating about -0.13 per unit of volatility. If you would invest 153.00 in Pmv Pharmaceuticals on November 3, 2024 and sell it today you would lose (11.00) from holding Pmv Pharmaceuticals or give up 7.19% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Virax Biolabs Group vs. Pmv Pharmaceuticals
Performance |
| Timeline |
| Virax Biolabs Group |
| Pmv Pharmaceuticals |
Virax Biolabs and Pmv Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Virax Biolabs and Pmv Pharmaceuticals
The main advantage of trading using opposite Virax Biolabs and Pmv Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Virax Biolabs position performs unexpectedly, Pmv Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pmv Pharmaceuticals will offset losses from the drop in Pmv Pharmaceuticals' long position.| Virax Biolabs vs. Revelation Biosciences | Virax Biolabs vs. Kiora Pharmaceuticals | Virax Biolabs vs. Quoin Pharmaceuticals Ltd | Virax Biolabs vs. Cardio Diagnostics Holdings |
| Pmv Pharmaceuticals vs. MediciNova | Pmv Pharmaceuticals vs. Pharvaris BV | Pmv Pharmaceuticals vs. PepGen | Pmv Pharmaceuticals vs. Anebulo Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Complementary Tools
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |